BENTONVILLE, Ariz., Feb. 27, 2018 -- via OTC PR WIRE-- Glucose Health, Inc. (OTC:GLUC) today announced the completion of its second TV commercial to support national expansion of its newest diabetic nutritional product, Glucose Health® Diabetic-Friendly Iced Tea. The key message to consumers of the 30 second commercial is “The Iced Tea That’s Good for You!”
The new TV commercial will be part of a national multi-channel media strategy to support Glucose Health® Diabetic-Friendly Iced Tea national sales expansion though “brick & mortar” retailer partners.
Watch the new TV commercial at the Glucose Health, Inc. corporate website at this link.
Glucose Health® Diabetic-Friendly Iced Tea Mix is more than just a delicious, sugar-free and decaffeinated iced tea – it’s also a potent nutritional supplement. Glucose Health® is enriched with key micronutrients relevant to persons concerned about diabetes, including Vitamins B6, B7, B12 and high bioavailability forms of the trace elements Manganese, Chromium and Zinc. Additionally, every serving of Glucose Health® Diabetic-Friendly Iced Tea includes 100% soluble fiber, clinically proven in research published in peer-reviewed medical journals to help “block” the body’s absorption of dietary sugars (and dietary fats) and to help moderate rising blood sugar levels, after meals.
About Glucose Health, Inc. (OTC:GLUC)
Glucose Health® Diabetic-Friendly Iced Tea Mix is a unique and compelling functional beverage which serves the fast-growing over-the-counter (non-prescription) diabetic nutritionals category. Glucose Health, Inc. is publicly-traded with the ticker symbol (OTC:GLUC). Glucose Health® products are manufactured in the USA in Arkansas and Minnesota.
Contact:
Glucose Health, Inc.
Murray Fleming
(888) 987-6315


SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth 



